Total Payments
$4,989
2024 Payments
$468.23
Companies
46
Transactions
197
Medicare Patients
11,318
Medicare Billing
$826,315
Payment Breakdown by Category
Food & Beverage$4,612 (92.4%)
Education$377.31 (7.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,612 | 191 | 92.4% |
| Education | $377.31 | 6 | 7.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $665.78 | 7 | $0 (2019) |
| Janssen Biotech, Inc. | $456.66 | 25 | $0 (2024) |
| Astellas Pharma US Inc | $402.34 | 17 | $0 (2024) |
| ABBVIE INC. | $338.57 | 22 | $0 (2024) |
| Antares Pharma, Inc. | $294.66 | 19 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $261.10 | 4 | $0 (2019) |
| Coloplast Corp | $259.47 | 7 | $0 (2022) |
| Boston Scientific Corporation | $246.70 | 6 | $0 (2023) |
| PROCEPT BioRobotics Corporation | $185.61 | 2 | $0 (2024) |
| Rochester Medical Corporation | $180.97 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $468.23 | 21 | Endo USA, Inc. ($65.33) |
| 2023 | $437.29 | 16 | PROCEPT BioRobotics Corporation ($152.58) |
| 2022 | $651.99 | 30 | UroGen Pharma, Inc. ($139.34) |
| 2021 | $423.50 | 25 | AbbVie Inc. ($62.15) |
| 2020 | $289.57 | 13 | Rochester Medical Corporation ($180.97) |
| 2019 | $1,316 | 38 | Dendreon Pharmaceuticals LLC ($314.12) |
| 2018 | $843.41 | 33 | Dendreon Pharmaceuticals LLC ($285.43) |
| 2017 | $559.21 | 21 | NxThera, Inc. ($126.84) |
All Payment Transactions
197 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $33.03 | General |
| Category: UROLOGY | ||||||
| 11/08/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: UROLOGY | ||||||
| 10/10/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/30/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $16.45 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/07/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Oncology | ||||||
| 07/10/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $62.50 | General |
| Category: Surgical Care | ||||||
| 06/13/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Diagnostic Imaging | ||||||
| 05/30/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $19.94 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Oncology | ||||||
| 05/10/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: UROLOGY | ||||||
| 05/07/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: UROLOGY | ||||||
| 04/04/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/04/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 03/21/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Urology | ||||||
| 03/14/2024 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: UROLOGY | ||||||
| 03/07/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $15.40 | General |
| Category: ONCOLOGY | ||||||
| 01/05/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Diagnostic Imaging | ||||||
| 12/08/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/10/2023 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 10/27/2023 | Supernus Pharmaceuticals, Inc. | TLANDO (Drug), XYOSTED | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/17/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,600 | 7,276 | $527,700 | $192,225 |
| 2022 | 28 | 3,010 | 7,346 | $674,608 | $222,035 |
| 2021 | 25 | 2,953 | 7,580 | $657,549 | $228,111 |
| 2020 | 28 | 2,755 | 3,895 | $592,399 | $183,944 |
Total Patients
11,318
Total Services
26,097
Medicare Billing
$826,315
Procedure Codes
122
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 614 | 903 | $179,847 | $79,154 | 44.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 110 | 148 | $53,704 | $26,152 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 220 | 248 | $33,232 | $15,115 | 45.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 11 | 68 | $45,900 | $9,015 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 72 | 115 | $35,103 | $7,850 | 22.4% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 16 | 3,500 | $17,500 | $7,649 | 43.7% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 16 | 18 | $15,768 | $5,727 | 36.3% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 16 | 69 | $14,007 | $4,385 | 31.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 415 | 587 | $18,784 | $4,353 | 23.2% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 20 | 36 | $37,266 | $4,322 | 11.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 185 | 222 | $11,100 | $4,000 | 36.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $11,696 | $3,774 | 32.3% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 20 | 20 | $7,920 | $3,679 | 46.5% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 12 | 13 | $5,590 | $3,203 | 57.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $5,400 | $2,315 | 42.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 481 | 669 | $3,345 | $2,278 | 68.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 164 | 185 | $4,625 | $1,546 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 29 | 35 | $7,483 | $1,546 | 20.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 15 | 15 | $6,075 | $1,507 | 24.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 23 | $2,760 | $1,131 | 41.0% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 13 | 16 | $2,416 | $921.40 | 38.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 11 | 12 | $3,525 | $658.32 | 18.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 18 | 25 | $1,250 | $632.26 | 50.6% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 21 | 31 | $1,241 | $587.45 | 47.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 11 | 14 | $756.00 | $330.94 | 43.8% |
About Dr. Marcus Austenfeld, M.D
Dr. Marcus Austenfeld, M.D is a Urology healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2012. The National Provider Identifier (NPI) number assigned to this provider is 1114284874.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marcus Austenfeld, M.D has received a total of $4,989 in payments from pharmaceutical and medical device companies, with $468.23 received in 2024. These payments were reported across 197 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($4,612).
As a Medicare-enrolled provider, Austenfeld has provided services to 11,318 Medicare beneficiaries, totaling 26,097 services with total Medicare billing of $826,315. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Kansas City, MO
- Active Since 04/19/2012
- Last Updated 01/15/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1114284874
Products in Payments
- PROVENGE (Drug) $697.22
- Erleada (Drug) $263.38
- Xofigo (Drug) $261.10
- TITAN (Device) $208.90
- XIAFLEX (Biological) $202.54
- LUPRON DEPOT (Drug) $194.09
- NOCDURNA (Drug) $187.54
- AMS (Device) $185.69
- ERLEADA (Drug) $167.72
- AQUABEAM ROBOTIC SYSTEM (Device) $152.58
- JELMYTO (Drug) $151.84
- XYOSTED (Drug) $140.32
- Rezum (Device) $126.84
- XTANDI (Drug) $115.22
- Axumin (Drug) $111.13
- ELIGARD (Drug) $109.79
- MYRBETRIQ (Drug) $88.43
- PYLARIFY (Drug) $79.92
- PERCLOT (Device) $62.50
- FIRMAGON (Drug) $58.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Kansas City
Wilson Molina, Md, MD
Urology — Payments: $340,886
Urology $340,886
Dr. Samuel Kuykendall, M.d, M.D
Urology — Payments: $159,847
Urology $159,847
Bristol Whiles, Md, MD
Urology — Payments: $102,131
Urology $102,131
Ahmad El-Arabi, M.d, M.D
Urology — Payments: $53,792
Urology $53,792
Dr. Jeffrey Holzbeierlein, Md, MD
Urology — Payments: $50,322
Urology $50,322
Dr. David Duchene, Md, MD
Urology — Payments: $33,788
Urology $33,788